Trulson M E, Keltch G F
Eur J Pharmacol. 1985 Jan 15;108(1):33-7. doi: 10.1016/0014-2999(85)90280-8.
Chronic administration of 5-methoxy-N,N-dimethyltryptamine (5-MeODMT, 2 mg/kg i.p., every 30 min for 4 h) produced a dramatic tolerance to the behavioral effects of the drug in rats. The ED50 for the syndrome-inducing effects of the drug was increased from 1.3 to 2.4 mg/kg, and the mean duration of the syndrome was decreased from 14.9 to 1.2 min after this treatment. This tolerance effect totally disappeared within 4 h following termination of drug treatment. This effect was not due to changes in the uptake of 5MeODMT into the brain, but rather appears to be due to a decrease in the binding of the drug to serotonin receptors in the central nervous system. These studies are in contrast to previous results which reported no development of tolerance to 5-MeODMT.
对大鼠慢性给予5-甲氧基-N,N-二甲基色胺(5-MeODMT,2毫克/千克,腹腔注射,每30分钟一次,共4小时)可使其对该药物的行为效应产生显著耐受性。药物诱导综合征效应的半数有效剂量(ED50)从1.3毫克/千克增加到2.4毫克/千克,且该综合征的平均持续时间在这种处理后从14.9分钟减少到1.2分钟。这种耐受效应在药物治疗终止后的4小时内完全消失。这种效应并非由于5-MeODMT进入大脑的摄取量发生变化,而是似乎归因于药物与中枢神经系统中血清素受体的结合减少。这些研究与之前报道的对5-MeODMT无耐受性发展的结果形成对比。